Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,345 | -69,410 | -51,925 | -94,226 | -282,024 |
| Depreciation Amortization | 1,269 | 37,504 | 37,627 | 37,697 | 37,955 |
| Accounts receivable | -14,142 | 4,046 | 994 | 11,297 | -24,027 |
| Other Working Capital | 16,472 | -39,676 | -20,727 | -1,443 | -105,611 |
| Other Operating Activity | 69,738 | 26,877 | 10,647 | -26,479 | 120,742 |
| Operating Cash Flow | $67,992 | $-40,659 | $-23,384 | $-73,154 | $-252,965 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 40,000 |
| PPE Investments | -119 | -33 | N/A | -114 | -59 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 40,000 |
| Other Investing Activity | -7,807 | 0 | 0 | 0 | -40,000 |
| Investing Cash Flow | $-7,926 | $-33 | $N/A | $-114 | $39,941 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 45,000 | N/A | -33,000 | 0 |
| Debt Repayment | -462 | -37,099 | -32,000 | N/A | 0 |
| Common Stock Issued | 68,363 | 43,034 | 6,794 | 7,598 | 88,948 |
| Other Financing Activity | -4,974 | -1,272 | 0 | 40,000 | 44,783 |
| Financing Cash Flow | $72,927 | $49,663 | $-25,206 | $14,598 | $133,731 |
| Beginning Cash Position | 53,550 | 44,579 | 93,169 | 151,839 | 231,132 |
| End Cash Position | 186,543 | 53,550 | 44,579 | 93,169 | 151,839 |
| Net Cash Flow | $132,993 | $8,971 | $-48,590 | $-58,670 | $-79,293 |
| Free Cash Flow | |||||
| Operating Cash Flow | 67,992 | -40,659 | -23,384 | -73,154 | -252,965 |
| Capital Expenditure | -291 | -33 | N/A | -114 | -59 |
| Free Cash Flow | 67,701 | -40,692 | -23,384 | -73,268 | -253,024 |